Low-moderate arsenic exposure and respiratory in American Indian communities in the Strong Heart Study.
Aged
Arsenic
/ adverse effects
Arsenicals
/ adverse effects
Drinking Water
/ analysis
Environmental Exposure
/ adverse effects
Female
Humans
Indians, North American
/ statistics & numerical data
Male
Middle Aged
Prospective Studies
Respiration Disorders
/ chemically induced
Risk Factors
United States
/ epidemiology
Water Pollutants, Chemical
/ adverse effects
Journal
Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645
Informations de publication
Date de publication:
28 11 2019
28 11 2019
Historique:
received:
17
04
2019
accepted:
28
10
2019
entrez:
30
11
2019
pubmed:
30
11
2019
medline:
9
4
2020
Statut:
epublish
Résumé
Arsenic exposure through drinking water is an established lung carcinogen. Evidence on non-malignant lung outcomes is less conclusive and suggests arsenic is associated with lower lung function. Studies examining low-moderate arsenic (< 50 μg/L), the level relevant for most populations, are limited. We evaluated the association of arsenic exposure with respiratory health in American Indians from the Northern Plains, the Southern Plains and the Southwest United States, communities with environmental exposure to inorganic arsenic through drinking water. The Strong Heart Study is a prospective study of American Indian adults. This analysis used urinary arsenic measurements at baseline (1989-1991) and spirometry at Visit 2 (1993-1995) from 2132 participants to evaluate associations of arsenic exposure with airflow obstruction, restrictive pattern, self-reported respiratory disease, and symptoms. Airflow obstruction was present in 21.5% and restrictive pattern was present in 14.4%. The odds ratio (95% confidence interval) for obstruction and restrictive patterns, based on the fixed ratio definition, comparing the 75th to 25th percentile of arsenic, was 1.17 (0.99, 1.38) and 1.27 (1.01, 1.60), respectively, after adjustments, and 1.28 (1.02, 1.60) and 1.33 (0.90, 1.50), respectively, based on the lower limit of normal definition. Arsenic was associated with lower percent predicted FEV1 and FVC, self-reported emphysema and stopping for breath. Low-moderate arsenic exposure was positively associated with restrictive pattern, airflow obstruction, lower lung function, self-reported emphysema and stopping for breath, independent of smoking and other lung disease risk factors. Findings suggest that low-moderate arsenic exposure may contribute to restrictive lung disease.
Sections du résumé
BACKGROUND
Arsenic exposure through drinking water is an established lung carcinogen. Evidence on non-malignant lung outcomes is less conclusive and suggests arsenic is associated with lower lung function. Studies examining low-moderate arsenic (< 50 μg/L), the level relevant for most populations, are limited. We evaluated the association of arsenic exposure with respiratory health in American Indians from the Northern Plains, the Southern Plains and the Southwest United States, communities with environmental exposure to inorganic arsenic through drinking water.
METHODS
The Strong Heart Study is a prospective study of American Indian adults. This analysis used urinary arsenic measurements at baseline (1989-1991) and spirometry at Visit 2 (1993-1995) from 2132 participants to evaluate associations of arsenic exposure with airflow obstruction, restrictive pattern, self-reported respiratory disease, and symptoms.
RESULTS
Airflow obstruction was present in 21.5% and restrictive pattern was present in 14.4%. The odds ratio (95% confidence interval) for obstruction and restrictive patterns, based on the fixed ratio definition, comparing the 75th to 25th percentile of arsenic, was 1.17 (0.99, 1.38) and 1.27 (1.01, 1.60), respectively, after adjustments, and 1.28 (1.02, 1.60) and 1.33 (0.90, 1.50), respectively, based on the lower limit of normal definition. Arsenic was associated with lower percent predicted FEV1 and FVC, self-reported emphysema and stopping for breath.
CONCLUSION
Low-moderate arsenic exposure was positively associated with restrictive pattern, airflow obstruction, lower lung function, self-reported emphysema and stopping for breath, independent of smoking and other lung disease risk factors. Findings suggest that low-moderate arsenic exposure may contribute to restrictive lung disease.
Identifiants
pubmed: 31779614
doi: 10.1186/s12940-019-0539-6
pii: 10.1186/s12940-019-0539-6
pmc: PMC6883619
doi:
Substances chimiques
Arsenicals
0
Drinking Water
0
Water Pollutants, Chemical
0
Arsenic
N712M78A8G
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104Subventions
Organisme : NIEHS NIH HHS
ID : P42ES010349
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025216
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001409
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01ES025216
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL109315, R01HL109301, R01HL109284, R01HL109282 and R01HL109319 and R01HL090863
Pays : United States
Organisme : NIEHS NIH HHS
ID : F31ES028597
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES009089
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025135
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01ES021367
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Lancet. 2007 Sep 1;370(9589):765-73
pubmed: 17765526
Am Indian Alsk Native Ment Health Res. 2000;9(3):20-37
pubmed: 11279560
Chest. 2001 Aug;120(2):489-95
pubmed: 11502648
Toxicol Appl Pharmacol. 2015 Sep 1;287(2):161-167
pubmed: 26048584
Int J Epidemiol. 2006 Aug;35(4):1001-8
pubmed: 16554379
PLoS One. 2013 Dec 06;8(12):e82970
pubmed: 24349408
Int Arch Occup Environ Health. 2011 Aug;84(6):591-600
pubmed: 20972800
J Expo Sci Environ Epidemiol. 2009 May;19(4):343-8
pubmed: 19190673
Am J Epidemiol. 2005 Sep 15;162(6):533-41
pubmed: 16093295
Diabetes Care. 2011 Oct;34(10):2306-13
pubmed: 21852681
Environ Health. 2013 Sep 02;12(1):73
pubmed: 24004508
Curr Environ Health Rep. 2016 Mar;3(1):1-12
pubmed: 26875182
Environ Health Perspect. 2006 Aug;114(8):1293-6
pubmed: 16882542
Am J Respir Crit Care Med. 2008 Feb 1;177(3):253-60
pubmed: 18006882
Environ Res. 2016 May;147:537-55
pubmed: 26891939
Curr Environ Health Rep. 2018 Jun;5(2):244-254
pubmed: 29637476
N Engl J Med. 1994 Jul 7;331(1):25-30
pubmed: 8202099
Int J Environ Health Res. 2002 Jun;12(2):175-9
pubmed: 12400554
Soc Psychiatry Psychiatr Epidemiol. 2005 Apr;40(4):291-9
pubmed: 15834780
Environ Res. 2015 Oct;142:273-80
pubmed: 26186135
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Respir Med. 2011 Jun;105(6):907-15
pubmed: 21295958
Am J Epidemiol. 1990 Dec;132(6):1141-55
pubmed: 2260546
Environ Health Perspect. 2007 Apr;115(4):586-91
pubmed: 17450228
Anal Methods. 2012;4(2):406-413
pubmed: 22685491
Am J Epidemiol. 2012 Nov 15;176(10):865-74
pubmed: 23097256
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S169-75
pubmed: 26595735
Int J Gen Med. 2010 Oct 20;3:335-43
pubmed: 21116339
J Toxicol Environ Health A. 2011;74(11):716-27
pubmed: 21480046
Toxicol Appl Pharmacol. 2016 Dec 15;313:10-15
pubmed: 27725189
Toxicol Sci. 2007 Nov;100(1):75-87
pubmed: 17682005
J Assoc Physicians India. 2004 May;52:395-400
pubmed: 15656029
Am J Physiol Lung Cell Mol Physiol. 2008 Aug;295(2):L293-302
pubmed: 18539681
Environ Health Perspect. 2009 Sep;117(9):1428-33
pubmed: 19750109
Environ Health Perspect. 2006 May;114(5):641-8
pubmed: 16675414
Diabet Med. 2010 Sep;27(9):977-87
pubmed: 20722670
Curr Environ Health Rep. 2017 Jun;4(2):229-243
pubmed: 28488132
Eur Respir J. 2002 Nov;20(5):1117-22
pubmed: 12449163